Michal Berkner - McDermott Will & Emery


Michal Berkner is a partner in the London transactions practice and is one of Europe’s preeminent M&A practitioners within the life sciences, healthcare and technology sectors. She advises major strategic buyers and sellers in game-changing public and private transactions, including cross-border deals, negotiated and unsolicited transactions, takeover defenses, corporate governance, and joint ventures.

Michal who is dual qualified (New York and England and Wales) is ranked as a leading individual in Chambers Global and Chambers UK. She also received a highly commended distinction in the Women in Law category at The British Legal Awards 2019. In 2017, Michal was included in the Financial Times HERoes list, which recognizes the top 50 female champions of women in business in the UK and Ireland. Over her 27 year legal career based in New York and London she has advised on some of the largest and most complex global M&A transactions.



  • Advised a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by a leading gastrointestinal (GI) healthcare company, with an estimated aggregate consideration of approximately $1 billion*
  • Advised a global biopharmaceutical company on its agreement to combine with One of Europe’s leading and life sciences investment firms (a SPAC) for $248 million*
  • Advised a public biopharmaceutical company on its agreement to buy the US rights for FYCOMPA (perampanel) CIII.FY from a leading research-based pharmaceutical company*

Show More


  • The Legal 500 UK, Recommended, 2024
  • Chambers UK 2024, Corporate/M&A


University of Pennsylvania Law School, JD, 1997
Johns Hopkins University, BA, 1994

England and Wales
New York